{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T10:23:19Z","timestamp":1768213399182,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Dutch Federation Medical Specialist","award":["59825882"],"award-info":[{"award-number":["59825882"]}]},{"name":"AIDSfonds","award":["p-61803"],"award-info":[{"award-number":["p-61803"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>HIV indicator condition-guided testing is recommended by guidelines to identify undiagnosed HIV infections. However, general practitioners (GPs) frequently see patients for indicator conditions without testing them for HIV. The aim of this study was to evaluate whether implementing HIV teams, using trained GP ambassadors, promoted local HIV indicator condition-guided testing practices in urban GP centers in the Netherlands.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a prospective implementation study between May 2021 and March 2023. Patients\u2009\u2265\u200918 years newly diagnosed with HIV indicator conditions in three GP centers were included. The intervention consisted of HIV expert led education for GPs with a stepwise implementation of point-of-care testing (phase 1), followed by adding peer-to-peer case feedback by trained GP ambassadors (phase 2). Questionnaires were used to assess the experiences and beliefs of HIV indicator condition-driven testing in patients and GPs. The primary outcome was the overall HIV testing rate in patients diagnosed with indicator conditions compared to pre-implementation. Secondary outcomes were HIV testing rate per phase and per indicator condition, HIV positivity rate, and patients\u2019 and GPs\u2019 experiences with this testing strategy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In 132,338 patient visits, 846 (0.6%, 95%CI 0.6\u20130.7%) HIV indicator conditions were diagnosed, including 485 sexually transmitted infections (57.3%). Overall, 215 (25.4%) indicator conditions were tested for HIV after the implementation of HIV teams. The testing rate was comparable between the two phases (25.2% versus 25.9%, <jats:italic>p<\/jats:italic>\u2009=\u20090.83). The testing rates pre- and post-implementation were comparable (21.3% versus 25.4%, <jats:italic>p<\/jats:italic>\u2009=\u20090.33). The most frequently tested HIV indicator conditions were unexplained weight loss (<jats:italic>n<\/jats:italic>\u2009=\u200913, 41.9%), unexplained lymphadenopathy (<jats:italic>n<\/jats:italic>\u2009=\u20098, 38.1%), and sexually transmitted infections (<jats:italic>n<\/jats:italic>\u2009=\u2009161, 33.2%). Three patients (1.4%, 95%CI 0.3\u20134.0%) tested positive for HIV. Test acceptance in patients was high as was the self-perceived knowledge of GPs on HIV indicator conditions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Implementing HIV teams did not enhance HIV indicator condition-guided testing in urban GP centers from a low HIV prevalence setting. The high patients acceptance rate and self-perceived knowledge among GPs regarding HIV indicator conditions did not manifest in high HIV testing rates. Patients accepted testing, but a gap was found between the self-perceived knowledge of GPs regarding HIV indicator conditions and testing, and the actual HIV testing rate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov NCT05225493 (registration date: 17-01-2022).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-024-02666-0","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T12:07:51Z","timestamp":1735301271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Implementing HIV teams to improve HIV indicator condition-guided testing in general practitioner centers in the Netherlands"],"prefix":"10.1186","volume":"25","author":[{"given":"Carlijn C. E.","family":"Jordans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotte","family":"Niemantsverdriet \u2013 Rokx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan L.","family":"Struik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva C.","family":"van der Waal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul V. J. M.","family":"van der Voorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nienke","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelies","family":"Verbon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J. E.","family":"Bindels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casper","family":"Rokx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"2666_CR1","unstructured":"Europe ECfDPaCWrof. HIV\/AIDS surveillance in Europe \u2013\u20092022 data. 2023."},{"issue":"10189","key":"2666_CR2","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/S0140-6736(19)30418-0","volume":"393","author":"AJ Rodger","year":"2019","unstructured":"Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393(10189):2428\u201338.","journal-title":"Lancet"},{"issue":"1","key":"2666_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12981-016-0129-4","volume":"14","author":"G Guaraldi","year":"2017","unstructured":"Guaraldi G, Zona S, Menozzi M, Brothers TD, Carli F, Stentarelli C, et al. Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: an Italian cost impact study. AIDS Res Therapy. 2017;14(1):8.","journal-title":"AIDS Res Therapy"},{"issue":"10","key":"2666_CR4","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1016\/S2352-3018(17)30123-6","volume":"4","author":"RF Baggaley","year":"2017","unstructured":"Baggaley RF, Irvine MA, Leber W, Cambiano V, Figueroa J, McMullen H, et al. Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis. Lancet HIV. 2017;4(10):e465\u201374.","journal-title":"Lancet HIV"},{"issue":"9","key":"2666_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection","year":"2015","unstructured":"Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015;373(9):795\u2013807.","journal-title":"N Engl J Med"},{"issue":"2","key":"2666_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/hiv.12403","volume":"18","author":"D Tominski","year":"2017","unstructured":"Tominski D, Katchanov J, Driesch D, Daley MB, Liedtke A, Schneider A, et al. The late-presenting HIV-infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis. HIV Med. 2017;18(2):125\u201332.","journal-title":"HIV Med"},{"key":"2666_CR7","unstructured":"van Sighem AI, WFWNM, Boyd A, Smit C, Jongen VW, Matser A. Monitoring report 2023. Human Immunodeficiency Virus (HIV) Infection in the Netherlands.; 2023."},{"issue":"1","key":"2666_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12875-016-0556-2","volume":"17","author":"IK Joore","year":"2016","unstructured":"Joore IK, Twisk DE, Vanrolleghem AM, de Ridder M, Geerlings SE, van Bergen JEAM, et al. The need to scale up HIV indicator condition-guided testing for early case-finding: a case-control study in primary care. BMC Fam Pract. 2016;17(1):161.","journal-title":"BMC Fam Pract"},{"key":"2666_CR9","unstructured":"Ab E, Bruggeling NM, Donker GA, Posthuma J, Schep A, Stam AJ, Swarte CME, Van der Spruit R, Wittenberg. J. NHG-Standaard het soa-consult. 2023."},{"key":"2666_CR10","unstructured":"Europe Hi. HIV Indicator Conditions: Guidance for Implementing HIV Testing in Adults in Health Care Settings 2013 [ www.eurotest.org\/portals\/0\/Guidance.pdf.pdf"},{"key":"2666_CR11","unstructured":"RIVM L, HIV infectie richtlijn RIVM. 2014 [ https:\/\/lci.rivm.nl\/richtlijnen\/hivinfectie"},{"key":"2666_CR12","doi-asserted-by":"crossref","unstructured":"Boesecke C, Schellberg S, Schneider J, Schuettfort G, Stocker H. Prevalence, characteristics and challenges of late HIV diagnosis in Germany: an expert narrative review. Infection. 2023;51(3):529-537.","DOI":"10.1007\/s15010-023-02064-1"},{"issue":"1","key":"2666_CR13","doi-asserted-by":"publisher","first-page":"e009688","DOI":"10.1136\/bmjopen-2015-009688","volume":"6","author":"ELM Op de Coul","year":"2016","unstructured":"Op de Coul ELM, van Sighem A, Brinkman K, Benthem BHv E, MEvd, Geerlings S, et al. Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996\u20132014: results from a national observational cohort. BMJ Open. 2016;6(1):e009688.","journal-title":"BMJ Open"},{"issue":"7","key":"2666_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/sextrans-2015-052073","volume":"91","author":"IK Joore","year":"2015","unstructured":"Joore IK, Arts DL, Kruijer MJ, van Moll EP, Geerlings SE, Prins JM, et al. HIV indicator condition-guided testing to reduce the number of undiagnosed patients and prevent late presentation in a high-prevalence area: a case-control study in primary care. Sex Transm Infect. 2015;91(7):467\u201372.","journal-title":"Sex Transm Infect"},{"issue":"11","key":"2666_CR15","doi-asserted-by":"publisher","first-page":"e0140845","DOI":"10.1371\/journal.pone.0140845","volume":"10","author":"D Raben","year":"2015","unstructured":"Raben D, Mocroft A, Rayment M, Mitsura VM, Hadziosmanovic V, Sthoeger ZM, et al. Auditing HIV Testing Rates across Europe: results from the HIDES 2 study. PLoS ONE. 2015;10(11):e0140845.","journal-title":"PLoS ONE"},{"issue":"1","key":"2666_CR16","doi-asserted-by":"publisher","first-page":"e52845","DOI":"10.1371\/journal.pone.0052845","volume":"8","author":"AK Sullivan","year":"2013","unstructured":"Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S, et al. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLoS ONE. 2013;8(1):e52845.","journal-title":"PLoS ONE"},{"issue":"1","key":"2666_CR17","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1186\/s12889-018-6107-0","volume":"18","author":"J Deblonde","year":"2018","unstructured":"Deblonde J, Van Beckhoven D, Loos J, Boffin N, Sasse A, N\u00f6stlinger C, et al. HIV testing within general practices in Europe: a mixed-methods systematic review. BMC Public Health. 2018;18(1):1191.","journal-title":"BMC Public Health"},{"issue":"4","key":"2666_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/2325957414557268","volume":"15","author":"M Arya","year":"2016","unstructured":"Arya M, Patel S, Kumar D, Zheng MY, Kallen MA, Street RL Jr., et al. Why Physicians don\u2019t ask: interpersonal and intrapersonal barriers to HIV Testing-making a case for a patient-initiated campaign. J Int Assoc Provid AIDS Care. 2016;15(4):306\u201312.","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"2666_CR19","unstructured":"van Sighem A, Wit F, Boyd A, Smit C, Matser A, van der Valk. M. HIV Monitoring Report 2022. 2022."},{"key":"2666_CR20","first-page":"D965","volume":"161","author":"ELM Op de Coul","year":"2017","unstructured":"Op de Coul ELM, Joore IK, van Sighem A, Bom BCJ, Hillebregt M, Prins JM, et al. [Mapping HIV prevalence in the Netherlands with geographic information systems] hiv-bestrijding begint met GIS-werk. Ned Tijdschr Geneeskd. 2017;161:D965.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"2666_CR21","unstructured":"Prevention CfDCa. Evaluation Toolkit: Patient and Provider Perspectives about Routine HIV screening in Health Care Settings. 2012."},{"issue":"1","key":"2666_CR22","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1146\/annurev.micro.50.1.825","volume":"50","author":"GP Fauci","year":"1996","unstructured":"Fauci GP. IMMUNOPATHOGENESIS OF HIV INFECTION. Annu Rev Microbiol. 1996;50(1):825\u201354.","journal-title":"Annu Rev Microbiol"},{"issue":"5","key":"2666_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/sextrans-2015-052328","volume":"92","author":"C Agust\u00ed","year":"2016","unstructured":"Agust\u00ed C, Montoliu A, Mascort J, Carrillo R, Almeda J, Elorza JM, et al. Missed opportunities for HIV testing of patients diagnosed with an indicator condition in primary care in Catalonia, Spain. Sex Transm Infect. 2016;92(5):387\u201392.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"2666_CR24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/sextrans-2018-053792","volume":"95","author":"L Cayuelas Redondo","year":"2019","unstructured":"Cayuelas Redondo L, Ru\u00edz M, Kostov B, Sequeira E, Noguera P, Herrero MA, et al. Indicator condition-guided HIV testing with an electronic prompt in primary healthcare: a before and after evaluation of an intervention. Sex Transm Infect. 2019;95(4):238\u201343.","journal-title":"Sex Transm Infect"},{"issue":"1","key":"2666_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12875-023-02161-y","volume":"24","author":"S Bogers","year":"2023","unstructured":"Bogers S, Nieuwkerk P, van Dijk N, van der Schim M, Geerlings S, van Bergen J, et al. Understanding the effect of an educational intervention to optimize HIV testing strategies in primary care in Amsterdam - results of a mixed-methods study. BMC Prim Care. 2023;24(1):201.","journal-title":"BMC Prim Care"},{"issue":"1","key":"2666_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12875-018-0880-9","volume":"19","author":"CF Davies","year":"2018","unstructured":"Davies CF, Kesten JM, Gompels M, Horwood J, Crofts M, Billing A, et al. Evaluation of an educational intervention to increase HIV-testing in high HIV prevalence general practices: a pilot feasibility stepped-wedged randomised controlled trial. BMC Fam Pract. 2018;19(1):195.","journal-title":"BMC Fam Pract"},{"issue":"1","key":"2666_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1748-5908-1-9","volume":"1","author":"SJ Hysong","year":"2006","unstructured":"Hysong SJ, Best RG, Pugh JA. Audit and feedback and clinical practice guideline adherence: making feedback actionable. Implement Sci. 2006;1(1):9.","journal-title":"Implement Sci"},{"issue":"3","key":"2666_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1089\/apc.2021.0225","volume":"36","author":"J Zucker","year":"2022","unstructured":"Zucker J, Purpura L, Sani F, Huang S, Schluger A, Ruperto K, et al. Individualized provider feedback increased HIV and HCV Screening and Identification in a New York City Emergency Department. AIDS Patient Care STDS. 2022;36(3):106\u201314.","journal-title":"AIDS Patient Care STDS"},{"issue":"10","key":"2666_CR29","doi-asserted-by":"publisher","first-page":"e13132","DOI":"10.1371\/journal.pone.0013132","volume":"5","author":"Y Yazdanpanah","year":"2010","unstructured":"Yazdanpanah Y, Sloan CE, Charlois-Ou C, Le Vu S, Semaille C, Costagliola D, et al. Routine HIV screening in France: clinical impact and cost-effectiveness. PLoS ONE. 2010;5(10):e13132.","journal-title":"PLoS ONE"},{"issue":"5","key":"2666_CR30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.healthpol.2018.03.007","volume":"122","author":"F Bert","year":"2018","unstructured":"Bert F, Gualano MR, Biancone P, Brescia V, Camussi E, Martorana M, et al. Cost-effectiveness of HIV screening in high-income countries: a systematic review. Health Policy. 2018;122(5):533\u201347.","journal-title":"Health Policy"},{"issue":"Suppl 3","key":"2666_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/hiv.12064","volume":"14","author":"I Menacho","year":"2013","unstructured":"Menacho I, Sequeira E, Muns M, Barba O, Leal L, Clusa T, et al. Comparison of two HIV testing strategies in primary care centres: indicator-condition-guided testing vs. testing of those with non-indicator conditions. HIV Med. 2013;14(Suppl 3):33\u20137.","journal-title":"HIV Med"},{"key":"2666_CR32","doi-asserted-by":"publisher","first-page":"100229","DOI":"10.1016\/j.eclinm.2019.11.022","volume":"19","author":"W Leber","year":"2020","unstructured":"Leber W, Panovska-Griffiths J, Martin P, Morris S, Capelas Barbosa E, Estcourt C, et al. Evaluating the impact of post-trial implementation of RHIVA nurse-led HIV screening on HIV testing, diagnosis and earlier diagnosis in general practice in London. UK EClinicalMedicine. 2020;19:100229.","journal-title":"UK EClinicalMedicine"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-024-02666-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-024-02666-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-024-02666-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T13:02:25Z","timestamp":1735304545000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-024-02666-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2666"],"URL":"https:\/\/doi.org\/10.1186\/s12875-024-02666-0","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study procedures were carried out in accordance with the regulations of the Declaration of Helsinki. Approval of the research Medical Ethics Committee, Erasmus University Medical Center, Rotterdam, was obtained (MEC-2021-0277). The Medical Ethics Committee determined that this research did not meet the definition of medical research involving human subjects under Dutch law (WMO) and waived the need for individual informed consent with the use of data from routine care without processing of personal data. Separate informed consent was obtained from all participants who filled in the questionnaire before data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CJ received travel funding from Gilead Sciences and received speaker funding from ViiV Healthcare, both outside the submitted work. CR received funding for investigator-initiated studies, and reimbursement for travel and participation in scientific advisory boards, from Gilead Sciences and ViiV Healthcare. Other authors reported no disclosures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"440"}}